{"data":{"id":"us-nv/nrs-631.391","jurisdiction":"us-nv","citation":"NRS 631.391","heading":"Regulations for administration of certain neuromodulators related to Clostridium botulinum and dermal or soft tissue fillers; proof of training.","body":"1. The Board shall adopt regulations prescribing the training that a dentist must receive before injecting:\n(a) A neuromodulator that is derived from Clostridium botulinum;\n(b) A neuromodulator that is biosimilar to or the bioequivalent of a neuromodulator described in paragraph (a); or\n(c) Dermal or soft tissue fillers.\n2. A dentist who has received the training prescribed pursuant to subsection 1 shall present proof of such training upon the request of a patient or any state or local governmental agency or agent thereof.\n3. As used in this section “dermal or soft tissue filler” has the meaning ascribed to it in NRS 629.086.","path":["TITLE 54 — PROFESSIONS, OCCUPATIONS AND BUSINESSES","CHAPTER 631 - DENTISTRY, DENTAL HYGIENE, DENTAL THERAPY AND EXPANDED FUNCTION DENTAL ASSISTANCE","MISCELLANEOUS PROVISIONS"],"source_url":"https://www.leg.state.nv.us/NRS/NRS-631.html#NRS631Sec391","current_through":"2025 session (NRS as revised 2026-08-25)","vintage":"","retrieved_at":"2026-09-03T05:51:44Z","sha256":"0e22e50687570599e05b72253850c390b1de32e8d5a6be992213d4948c95085b","source_id":"us-nv","stale":true,"prev":"us-nv/nrs-631.389","next":"us-nv/nrs-631.392"},"notice":"GroundRules: Original legal text. Not legal advice."}